Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €153.70M
    Cost of goods sold
    €96.45M
    Gross profit
    €57.25M
    SG&A expenses
    €3.60M
    R&D expenses
    €5.90M
    EBITDA
    €42.67M
    D&A
    €0.00
    EBIT
    €42.30M
    Interest expenses
    €400.33K
    EBT
    €42.27M
    Tax expenses
    €6.45M
    Net income
    €35.82M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €13.97M
    Changes in working capital
    €0.00
    Operating cash flow
    €13.97M
    Capex
    €47.43M
    Other investing cash flow
    €68.65K
    Net investing cash flow
    -€36.16M
    Total cash dividends paid
    -€8.14M
    Issuance of common stock
    €0.00
    Debt repayment
    €28.21M
    Other financing cash flow
    -€332.10K
    Net financing cash flow
    €19.74M
    Foreign exchange effects
    -€107.48K
    Net change in cash
    €29.77M
    Cash at end of period
    €47.78M
    Free cash flow
    €61.41M

    Balance sheet

    Cash and cash equivalents
    €55.13M
    Cash and short-term investments
    €75.15M
    Total receivables
    €32.61M
    Inventory
    €26.11M
    Other current assets
    €1.63M
    Total current assets
    €135.50M
    Property, plant & equipment
    €125.17M
    Goodwill
    €0.00
    Intangible assets
    €2.02M
    Long-term investments
    €0.00
    Other non-current assets
    €17.53M
    Total non-current assets
    €145.57M
    Total assets
    €281.07M
    Accounts payable
    €16.31M
    Short-term debt
    €26.64M
    Other current liabilities
    €3.81M
    Total current liabilities
    €48.79M
    Long-term debt
    €10.28M
    Deferred tax liabilities
    €354.01K
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €13.89M
    Total liabilities
    €62.68M
    Common stock
    €50.85M
    Retained earnings
    €112.17M
    Other equity
    €0.00
    Total equity
    €218.39M
    Total liabilities and shareholders' equity
    €281.07M

    Company information

    Market capitalization
    €1.03B
    Employees
    988
    Enterprise Value
    €6.90B

    Company ratios

    Gross margin
    37.2%
    EBITDA margin
    27.8%
    EBIT margin
    27.5%
    EBT margin
    27.5%
    Net margin
    23.3%
    ROE
    16.4%
    ROA
    12.7%
    Asset turnover
    54.7%
    FCF margin
    -21.8%
    FCF yield
    -3.2%
    Efficiency ratio
    72.2%
    Net sales per employee
    €155.57K
    Net income per employee
    €36.25K

    Notifications